Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in OraSure Technologies, Inc. (NASDAQ:OSUR)

Universal Beteiligungs und Servicegesellschaft mbH bought a new position in OraSure Technologies, Inc. (NASDAQ:OSUR) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 14,476 shares of the medical instruments supplier’s stock, valued at approximately $49,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its stake in shares of OraSure Technologies by 202.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 5,234 shares during the last quarter. Causeway Capital Management LLC purchased a new position in shares of OraSure Technologies in the 4th quarter worth approximately $36,000. Raymond James Financial Inc. purchased a new position in shares of OraSure Technologies in the 4th quarter worth approximately $37,000. Boothbay Fund Management LLC purchased a new position in shares of OraSure Technologies in the 4th quarter worth approximately $42,000. Finally, Gotham Asset Management LLC purchased a new position in shares of OraSure Technologies in the 4th quarter worth approximately $43,000. Hedge funds and other institutional investors own 93.50% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on OSUR. Evercore ISI reiterated an “in-line” rating and issued a $3.00 price objective on shares of OraSure Technologies in a research note on Monday, May 19th. Wall Street Zen upgraded OraSure Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, May 17th.

OraSure Technologies Price Performance

NASDAQ:OSUR opened at $3.12 on Wednesday. The company has a market cap of $233.38 million, a P/E ratio of -7.43 and a beta of 0.27. The stock’s fifty day moving average price is $3.05 and its two-hundred day moving average price is $3.22. OraSure Technologies, Inc. has a 1 year low of $2.36 and a 1 year high of $4.92.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.